Achillion Pharmaceuticals Inc. on Thursday closed a $10.4 million financing and announced the appointment of Michael Kishbauch as president and CEO. (BioWorld Today)

Achillion Gets $10.4M As Part Of Series D, Names New CEO

Sep. 3, 2004

By Kim Coghill

No Comments

Achillion Pharmaceuticals Inc. on Thursday closed a $10.4 million financing and announced the appointment of Michael Kishbauch as president and CEO. (BioWorld Today)

MDS Paying Applied Biosystems $40M For MALDI Product Line IP

Sep. 2, 2004

By Kim Coghill

No Comments

MDS Paying Applied Biosystems $40M For MALDI Product Line IP

Sep. 2, 2004

By Kim Coghill

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Articles by Kim Coghill

Push For Public Posting Of Clinical Trial Data Continues

Push For Public Posting Of Clinical Trial Data Continues

Encysive Brings In $30.8M, Presents Thelin Data At ERS

Encysive Brings In $30.8M, Presents Thelin Data At ERS

States Angling To Control Reimportation, Stem Cells

States Angling To Control Reimportation, Stem Cells

Achillion Gets $10.4M As Part Of Series D, Names New CEO

Achillion Gets $10.4M As Part Of Series D, Names New CEO

MDS Paying Applied Biosystems $40M For MALDI Product Line IP

MDS Paying Applied Biosystems $40M For MALDI Product Line IP

Today's news in brief

Today's news in brief

J&J’s Ottava robotic system approved for US pivotal trial

‘Evo’ AI can design complete genomes

Medtronic receives CE mark for next generation Endoflip system